ADVANEX INC. Flash Report(Consolidated Basis) --Summary Results for fis cal year ended March 31, 2026
May 15, 2026
Company name: ADVANEX INC. Stock listings: Tokyo Stock Exchange
Code number: 5998 URL https://www.advanex.co.jp Representative: Eitaro Asada, Chairman & President
Inquiries: Tetsuya Yoshihara, Executive Director & CFO Telephone: +81-3-3822-5865 Date of the General Meeting of the Shareholders : June 25, 2026
Expected date of payment for dividends June 26, 2026
Filing date of securities report: June 22, 2026 Supplementary explanation material for financial results Yes
Holding of presentation meeting for financial results Yes
(Figures less than ¥1 million have been omitted.)
-
Performance
-
Operating results
Years ended March 31 Percentages indicate year-on-year increase (decrease).
Net sales
Operating income
Ordinary income
Net income
Millions of yen
%
Millions of yen
%
Millions of yen
%
Millions of yen
%
2026
29,679
4.0
1,322
19.2
1,343
(687.0
1,027
-
2025
28,532
7.5
1,109
203.1
170
(79.5)
(628)
-
Note: Comprehensive income(millions of yen): Mar. 2026: 2,162 -% Mar.2025: (113) -%
Net income per share
Net income per share after dilution
Return on equity
Ratio of ordinary income to total assets
Ratio of operating income to net sales
Yen
Yen
%
%
%
2026
250.40
250.04
11.3
4.4
4.5
2025
(153.13)
-
(7.7)
0.6
3.9
-
Consolidated Financial position
At March 31 (Figures less than ¥1 million have been omitted.)
Total assets
Net assets
Equity ratio
Net assets per share
Millions of yen
Millions of yen
%
Yen
2026
32,720
10,172
31.1
2,476.07
2025
28,505
8,093
28.4
1,969.08
(Reference) Total shareholders' equity: March 31, 2026: ¥10,164 million, March 31, 2025: ¥8,084 million
- Cash flows
Years ended March 31 (Figures less than ¥1 million have been omitted.)
Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Cash and cash equivalents at end of year
Millions of yen
Millions of yen
Millions of yen
Millions of yen
2026
2,291
(3,221)
1,550
5,158
2025
509
(1,302)
912
4,111
-
Operating results
-
Dividends
Years ended March 31
Record date
Dividends per share
First quarter
-end dividends
Second quarter
-end dividends
Third quarter
-end dividends
Year-end dividends
Total
Yen
Yen
Yen
Yen
Yen
2025
---
---
---
20.00
20.00
2026
---
---
---
35.00
35.00
2027
(Forecast)
---
--
---
50.00
50.00
Note: The expected dividend amount has not been decided.
Record date
Total amount of dividends
(for the entire fiscal year)
Payout ratio
(consolidated)
Dividends-to-net assets ratio (consolidated)
Millions of yen
%
%
2025
82
-
1.0
2026
143
14.0
1.6
2027
(Forecast)
19.7
-
Forecasts for the Fiscal Year Ended March 31, 2027
Percentages indicate year-on-year increase (decrease).
Net sales
Operating income
Ordinary income
Millions of yen
%
Millions of yen
%
Millions of yen
%
Fiscal year
30,000
1.1
1,500
13.4
1,200
(10.7)
Net income (loss)
Net income (loss) per share
Millions of yen %
Yen
Fiscal year
2,000 94.6
487.16
-
Other
Significant changes in subsidiaries during the subject fiscal year (Transfer of particular subsidiaries following a change in the scope of consolidation): No
Changes in accounting principles, procedures, presentations, etc.
Changes associated with revision of accounting standards, etc: Yes
Changes other than a.: No
Changes in accounting estimates: No
Restatement: No
Number of shares outstanding (Common stock)
Number of shares outstanding at fiscal year-end(including treasury stock): 2026: 4,153,370 shares 2025: 4,153,370 shares
Number of shares of treasury stock at fiscal year-end:
2026: 48,442 shares 2025: 47,469 shares Average Number of outstanding at term-end:
2026: 4,105,405 shares 2025: 4,106,318 shares
(Reference) FLASH REPORT (NON-CONSOLIDATED BASIS)-
Operating results
Years ended March 31 Percentages indicate year-on-year increase (decrease).
Net sales
Operating income
Ordinary income
(loss)
Net income
Millions of yen
%
Millions of yen
%
Millions of yen
%
Millions of yen
%
2026
10,506
2.5
255
15.7
462
(65.6)
196
(66.5)-
2025
10,245
2.6
220
82.6
1,346
147.2
586
-
Net income per share
Net income per share after dilution
Yen
Yen
2026
47.74
-
2025
142.87
-
- Financial pos ition
At March 31
Total assets
Net assets
Equity ratio
Net assets per share
Millions of yen
Millions of yen
%
Yen
2026
20,323
1,629
8.0
394.81
2025
17,837
1,489
8.3
360.64
(Reference) Total shareholders' equity: March 31, 2026 ¥1,620 million, March 31, 2025: ¥1,480 million
Notes
Audit procedures for financial statements under the Financial Instruments and Exchange Law are not completed at the
time of disclosure of this Brief Report of Financial Results.
・The business forecasts presented in this report are based on information available to the management at the time of preparation, and are subject to a number of risks and uncertainties. Actual results may differ materially from those projected due to a wide range of factors.
Index
Overview of Business Performance and Financial Position
Overview of Business performance ………………………………...……………………………… 5
Overview of Financial Position …………………………………...……………………………..... 6
The Status of Cash flow 6
Outlook for the coming fiscal year ….….….…….….….…….….….…….….….…….….….…….… 7
Basic Rationale Regarding Selection of Accounting Standards………………………………………… 7
Consolidated Financial Statements
Consolidated Balance Sheets …………………………………….………………………………….. 8
Consolidated Statements of Income and Consolidated Statements of
Comprehensive Income 11
Consolidated Statements of Cash Flows 14
Segment Information 16
-
Operating results
Non-Consolidated Financial Statements
Condensed Non-Consolidated Balance Sheets 17
Condensed Non-Consolidated Statements of Income 20
Overview of Business Performance and Financial Position
Overview of Operating Results for the Fiscal Year under Review
The Company operates in 12 countries including Japan, the Americas, Europe, and Asia, primarily manufacturing and selling precision metal processing components, including precision springs, for the automotive, medical, office automation equipment, and aircraft industries.
The business environment during the fiscal year under review remained unpredictable due to uncertain factors such as the impact of reciprocal tariffs by the U.S. government, the resulting effects on the global economy and exchange rates, and the deterioration of Japan-China relations. Despite this, the Company performed steadily overall, with the medical business continuing to expand.
Under these circumstances, net sales for the fiscal year under review increased 4.0% year-on-year to ¥29,679 million, operating profit increased 19.2% to ¥1,322 million, ordinary profit increased 687.0% to ¥1,343 million, and profit attributable to owners of parent was ¥1,027 million (compared to a loss of ¥628 million in the previous fiscal year).
Segment results were as follows.
[Japan]
Although sales to the office automation equipment sector decreased, sales to the automotive sector performed steadily, and sales to the medical, precision equipment, and information equipment sectors were also strong. As a result, net sales increased 1.2% year-on-year to ¥9,203 million, and segment profit increased 14.7% to ¥255 million.
[Americas]
With continued expansion in the medical sector and ongoing improvements at the Mexico plant, net sales increased 11.2% year-on-year to ¥6,014 million, and segment profit increased 43.4% to
¥276 million. [Europe]
Although the start of mass production for new medical business was delayed, recovery in the aircraft sector led to net sales increasing 4.2% year-on-year to ¥3,543 million. However, segment profit decreased 46.6% to ¥80 million due to increased fixed costs including upfront investments related to the medical business at the Czech plant.
[Asia]
With continued strong performance in the automotive and precision equipment sectors, net sales increased 2.7% year-on-year to ¥10,918 million, and segment profit increased 28.7% to ¥700 million.